Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	steroid hormone binding	ATP1A1 ATP1A3	8.16e-05	7	40	2	GO:1990239
GeneOntologyMolecularFunction	threonine-type endopeptidase activity	PSMB8 PSMB6	1.40e-04	9	40	2	GO:0004298
GeneOntologyMolecularFunction	P-type sodium transporter activity	ATP1A1 ATP1A3	1.74e-04	10	40	2	GO:0008554
GeneOntologyMolecularFunction	P-type sodium:potassium-exchanging transporter activity	ATP1A1 ATP1A3	1.74e-04	10	40	2	GO:0005391
GeneOntologyMolecularFunction	P-type potassium transmembrane transporter activity	ATP1A1 ATP1A3	2.13e-04	11	40	2	GO:0008556
GeneOntologyMolecularFunction	protein-folding chaperone binding	DNAJB1 ATP1A1 ATP1A3 PRNP	2.97e-04	161	40	4	GO:0051087
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	DNAJB1 BCL9L TCF4 ACTN4 IRS2 LDB1 CDC42SE2 NKX2-1 PRNP	3.89e-04	1160	40	9	GO:0030674
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	TCF4 KLF18 HOXB7 ACTN4 RUNX1 NKX2-4 ONECUT1 NKX2-1 LMX1A MYEF2	4.69e-04	1459	40	10	GO:0000977
GeneOntologyMolecularFunction	chromatin binding	TCF4 ACTN4 SFPQ LDB1 RUNX1 AKAP8 ONECUT1	5.93e-04	739	40	7	GO:0003682
GeneOntologyMolecularFunction	threonine-type peptidase activity	PSMB8 PSMB6	7.27e-04	20	40	2	GO:0070003
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	TCF4 HOXB7 RUNX1 ONECUT1 NKX2-1 LMX1A	8.08e-04	560	40	6	GO:0001228
GeneOntologyMolecularFunction	transcription coregulator activity	DNAJB1 BCL9L TCF4 ACTN4 LDB1 NKX2-1	8.23e-04	562	40	6	GO:0003712
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	TCF4 HOXB7 RUNX1 ONECUT1 NKX2-1 LMX1A	8.54e-04	566	40	6	GO:0001216
GeneOntologyMolecularFunction	ankyrin binding	FLNC ATP1A1	9.64e-04	23	40	2	GO:0030506
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TCF4 ACTN4 LDB1 RUNX1 AKAP8 NKX2-1	9.87e-04	582	40	6	GO:0140297
GeneOntologyMolecularFunction	amyloid-beta binding	ITM2C ATP1A3 PRNP	1.11e-03	102	40	3	GO:0001540
GeneOntologyMolecularFunction	cell adhesion molecule binding	DNAJB1 ACTN4 TAGLN2 PFKP SLAMF1 PSMB6	1.14e-03	599	40	6	GO:0050839
GeneOntologyMolecularFunction	molecular adaptor activity	DNAJB1 BCL9L TCF4 ACTN4 IRS2 LDB1 CDC42SE2 NKX2-1 PRNP	1.20e-03	1356	40	9	GO:0060090
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	TCF4 KLF18 HOXB7 RUNX1 NKX2-4 ONECUT1 NKX2-1 LMX1A MYEF2	1.59e-03	1412	40	9	GO:0000981
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP1A1 ATP1A3	2.36e-03	36	40	2	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP1A1 ATP1A3	2.36e-03	36	40	2	GO:0015662
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	TCF4 KLF18 HOXB7 RUNX1 NKX2-4 ONECUT1 NKX2-1 MYEF2	2.85e-03	1244	40	8	GO:0000978
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9L ACTN4 LDB1 NKX2-1	3.09e-03	303	40	4	GO:0003713
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	TCF4 KLF18 HOXB7 RUNX1 NKX2-4 ONECUT1 NKX2-1 MYEF2	3.26e-03	1271	40	8	GO:0000987
GeneOntologyMolecularFunction	phosphatidylinositol 3-kinase binding	IRS2 ATP1A1	3.35e-03	43	40	2	GO:0043548
GeneOntologyMolecularFunction	transcription factor binding	TCF4 ACTN4 LDB1 RUNX1 AKAP8 NKX2-1	3.62e-03	753	40	6	GO:0008134
GeneOntologyMolecularFunction	cadherin binding	DNAJB1 TAGLN2 PFKP PSMB6	4.61e-03	339	40	4	GO:0045296
GeneOntologyMolecularFunction	transmembrane transporter binding	ACTN4 ATP1A1 PRNP	4.91e-03	172	40	3	GO:0044325
GeneOntologyMolecularFunction	cytoskeletal protein binding	RANBP10 FLNC ACTN4 TAGLN2 ATP1A1 TAGLN PRNP	5.67e-03	1099	40	7	GO:0008092
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP1A1 ATP1A3	6.86e-03	62	40	2	GO:0019829
GeneOntologyMolecularFunction	general transcription initiation factor binding	TCF4 NKX2-1	7.29e-03	64	40	2	GO:0140296
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	ACTN4 LDB1 AKAP8 NKX2-1	9.47e-03	417	40	4	GO:0061629
GeneOntologyCellularComponent	beta-catenin-TCF complex	BCL9L TCF4 LDB1	1.83e-06	13	40	3	GO:1990907
GeneOntologyCellularComponent	photoreceptor inner segment membrane	ATP1A1 ATP1A3	2.14e-05	4	40	2	GO:0060342
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	BCL9L TCF4 SFPQ LDB1 RUNX1	1.63e-04	272	40	5	GO:0090575
GeneOntologyCellularComponent	proteasome core complex, beta-subunit complex	PSMB8 PSMB6	1.94e-04	11	40	2	GO:0019774
GeneOntologyCellularComponent	sodium:potassium-exchanging ATPase complex	ATP1A1 ATP1A3	2.33e-04	12	40	2	GO:0005890
GeneOntologyCellularComponent	chromatin	TCF4 HOXB7 SFPQ LDB1 RUNX1 AKAP8 NKX2-4 ONECUT1 NKX2-1 LMX1A	3.65e-04	1480	40	10	GO:0000785
GeneOntologyCellularComponent	neuron to neuron synapse	DNAJB1 ATP1A1 ATP1A3 HNRNPH1 HNRNPH2 PRNP	4.44e-04	523	40	6	GO:0098984
GeneOntologyCellularComponent	proteasome core complex	PSMB8 PSMB6	6.64e-04	20	40	2	GO:0005839
GeneOntologyCellularComponent	transcription regulator complex	BCL9L TCF4 SFPQ LDB1 RUNX1 NKX2-1	8.81e-04	596	40	6	GO:0005667
GeneOntologyCellularComponent	nuclear protein-containing complex	BCL9L LIG3 TCF4 SFPQ NUP188 LDB1 RUNX1 HNRNPH1 HNRNPH3	9.66e-04	1377	40	9	GO:0140513
GeneOntologyCellularComponent	postsynaptic density	DNAJB1 ATP1A1 HNRNPH1 HNRNPH2 PRNP	1.61e-03	451	40	5	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	DNAJB1 ATP1A1 HNRNPH1 HNRNPH2 PRNP	2.06e-03	477	40	5	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	DNAJB1 ATP1A1 HNRNPH1 HNRNPH2 PRNP	2.60e-03	503	40	5	GO:0099572
GeneOntologyCellularComponent	postsynapse	DNAJB1 ACTN4 ATP1A1 ATP1A3 HNRNPH1 HNRNPH2 PRNP	2.90e-03	1018	40	7	GO:0098794
GeneOntologyCellularComponent	cation-transporting ATPase complex	ATP1A1 ATP1A3	3.97e-03	49	40	2	GO:0090533
GeneOntologyCellularComponent	ATPase dependent transmembrane transport complex	ATP1A1 ATP1A3	4.97e-03	55	40	2	GO:0098533
GeneOntologyCellularComponent	sarcolemma	FLNC ATP1A1 ATP1A3	5.70e-03	190	40	3	GO:0042383
Domain	CH	FLNC ACTN4 TAGLN2 TAGLN	1.00e-05	65	39	4	SM00033
Domain	zf-RNPHF	HNRNPH1 HNRNPH2	1.27e-05	3	39	2	PF08080
Domain	Znf_CHHC	HNRNPH1 HNRNPH2	1.27e-05	3	39	2	IPR012996
Domain	CH	FLNC ACTN4 TAGLN2 TAGLN	1.35e-05	70	39	4	PF00307
Domain	-	FLNC ACTN4 TAGLN2 TAGLN	1.43e-05	71	39	4	1.10.418.10
Domain	CH	FLNC ACTN4 TAGLN2 TAGLN	1.59e-05	73	39	4	PS50021
Domain	CH-domain	FLNC ACTN4 TAGLN2 TAGLN	1.77e-05	75	39	4	IPR001715
Domain	Homeodomain-like	TCF4 HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	6.00e-05	332	39	6	IPR009057
Domain	CALPONIN_1	TAGLN2 TAGLN	6.34e-05	6	39	2	PS01052
Domain	CALPONIN_2	TAGLN2 TAGLN	6.34e-05	6	39	2	PS51122
Domain	Calponin_repeat	TAGLN2 TAGLN	6.34e-05	6	39	2	IPR000557
Domain	P-type_ATPase_IIC	ATP1A1 ATP1A3	6.34e-05	6	39	2	IPR005775
Domain	Calponin	TAGLN2 TAGLN	6.34e-05	6	39	2	PF00402
Domain	RRM_1	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	6.91e-05	208	39	5	PF00076
Domain	RRM	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	8.44e-05	217	39	5	SM00360
Domain	RRM_dom	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.04e-04	227	39	5	IPR000504
Domain	RRM	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.11e-04	230	39	5	PS50102
Domain	Homeobox	HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	1.20e-04	234	39	5	PF00046
Domain	HOMEOBOX_1	HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	1.25e-04	236	39	5	PS00027
Domain	HOX	HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	1.28e-04	237	39	5	SM00389
Domain	Homeobox_dom	HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	1.33e-04	239	39	5	IPR001356
Domain	HOMEOBOX_2	HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	1.33e-04	239	39	5	PS50071
Domain	-	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.46e-04	244	39	5	3.30.70.330
Domain	Pept_T1A_subB	PSMB8 PSMB6	1.89e-04	10	39	2	IPR000243
Domain	Nucleotide-bd_a/b_plait	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.90e-04	258	39	5	IPR012677
Domain	PROTEASOME_BETA_2	PSMB8 PSMB6	2.31e-04	11	39	2	PS51476
Domain	Proteasome_suB-type	PSMB8 PSMB6	2.31e-04	11	39	2	IPR023333
Domain	SM22_calponin	TAGLN2 TAGLN	2.31e-04	11	39	2	IPR003096
Domain	PROTEASOME_BETA_1	PSMB8 PSMB6	2.31e-04	11	39	2	PS00854
Domain	Proteasome_bsu_CS	PSMB8 PSMB6	2.77e-04	12	39	2	IPR016050
Domain	-	HOXB7 NKX2-4 ONECUT1 NKX2-1 LMX1A	2.91e-04	283	39	5	1.10.10.60
Domain	-	ATP1A1 ATP1A3	5.01e-04	16	39	2	1.20.1110.10
Domain	ATPase_P-typ_TM_dom	ATP1A1 ATP1A3	5.01e-04	16	39	2	IPR023298
Domain	ATPase_P-typ_cation-transptr_C	ATP1A1 ATP1A3	5.66e-04	17	39	2	IPR006068
Domain	Cation_ATPase_C	ATP1A1 ATP1A3	5.66e-04	17	39	2	PF00689
Domain	Homeobox_CS	HOXB7 NKX2-4 NKX2-1 LMX1A	5.96e-04	186	39	4	IPR017970
Domain	Cation_ATPase_N	ATP1A1 ATP1A3	6.36e-04	18	39	2	PF00690
Domain	Cation_ATPase_N	ATP1A1 ATP1A3	6.36e-04	18	39	2	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP1A1 ATP1A3	7.10e-04	19	39	2	IPR004014
Domain	Proteasome	PSMB8 PSMB6	7.10e-04	19	39	2	PF00227
Domain	Proteasome_sua/b	PSMB8 PSMB6	7.10e-04	19	39	2	IPR001353
Domain	Homeobox_metazoa	HOXB7 NKX2-4 NKX2-1	8.72e-04	90	39	3	IPR020479
Domain	Actinin_actin-bd_CS	FLNC ACTN4	1.05e-03	23	39	2	IPR001589
Domain	ACTININ_2	FLNC ACTN4	1.05e-03	23	39	2	PS00020
Domain	ACTININ_1	FLNC ACTN4	1.05e-03	23	39	2	PS00019
Domain	-	PSMB8 PSMB6	1.14e-03	24	39	2	3.60.20.10
Domain	-	ATP1A1 ATP1A3	2.03e-03	32	39	2	2.70.150.10
Domain	-	ATP1A1 ATP1A3	2.03e-03	32	39	2	3.40.1110.10
Domain	Ntn_hydrolases_N	PSMB8 PSMB6	2.15e-03	33	39	2	IPR029055
Domain	ATPase_P-typ_cyto_domN	ATP1A1 ATP1A3	2.42e-03	35	39	2	IPR023299
Domain	ATPase_P-typ_P_site	ATP1A1 ATP1A3	2.56e-03	36	39	2	IPR018303
Domain	P_typ_ATPase	ATP1A1 ATP1A3	2.56e-03	36	39	2	IPR001757
Domain	ATPASE_E1_E2	ATP1A1 ATP1A3	2.56e-03	36	39	2	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP1A1 ATP1A3	2.70e-03	37	39	2	IPR008250
Domain	E1-E2_ATPase	ATP1A1 ATP1A3	2.70e-03	37	39	2	PF00122
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	LIG3 FLNC ACTN4 ITM2C SFPQ TAGLN2 NUP188 ATP1A1 AKAP8 PFKP HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.83e-12	1024	40	14	24711643
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	DNAJB1 FLNC ACTN4 SFPQ TAGLN2 NUP188 PFKP HNRNPH1 HNRNPH2 HNRNPH3 PSMB6	3.07e-10	707	40	11	19738201
Pubmed	Proteome analysis of the circadian clock protein PERIOD2.	FLNC ACTN4 SFPQ TAGLN2 HNRNPH2 HNRNPH3	1.18e-09	94	40	6	35122331
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	FLNC ACTN4 TAGLN2 IDH2 ATP1A1 PFKP HNRNPH1 PSMB6	2.30e-09	312	40	8	37120454
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	DNAJB1 LIG3 FLNC ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 AKAP8 PFKP HNRNPH1 PSMB6	3.79e-09	1149	40	12	35446349
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	DNAJB1 SFPQ TAGLN2 NUP188 IDH2 PFKP HNRNPH1 HNRNPH2 PSMB6	7.94e-09	534	40	9	35032548
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	ACTN4 SFPQ ATP1A1 ATP1A3 PFKP HNRNPH1 MYEF2 HNRNPH2 PSMB6	1.06e-08	552	40	9	36293380
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	LIG3 SFPQ ATP1A1 LDB1 RUNX1 PFKP NKX2-4 HNRNPH1 HNRNPH2	1.69e-08	583	40	9	29844126
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	DNAJB1 ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 PFKP MYEF2 HNRNPH3 PSMB6	1.84e-08	803	40	10	36517590
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	FLNC ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 PFKP HNRNPH1 MYEF2 PSMB6	1.93e-08	807	40	10	30575818
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	DNAJB1 RANBP10 LIG3 SFPQ NUP188 EXTL3 IDH2 ATP1A1 LDB1 AKAP8 PFKP PSMB6	4.61e-08	1440	40	12	30833792
Pubmed	DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.	SFPQ ATP1A1 AKAP8 ATP1A3 HNRNPH1 HNRNPH2	4.96e-08	175	40	6	25756610
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9L SFPQ LDB1 AKAP8 PFKP HNRNPH1	5.86e-08	180	40	6	35198878
Pubmed	DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.	SFPQ AKAP8 HNRNPH1 HNRNPH2 HNRNPH3	6.00e-08	89	40	5	22446626
Pubmed	Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly.	SFPQ ATP1A1 PFKP HNRNPH1 PRNP	7.49e-08	93	40	5	38245532
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	ACTN4 SFPQ TAGLN2 NUP188 PFKP HNRNPH1 HNRNPH3 PSMB6	7.71e-08	491	40	8	22623428
Pubmed	VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.	DNAJB1 SFPQ TAGLN2 IDH2 ATP1A1 HNRNPH1 PSMB6	9.07e-08	329	40	7	35562734
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	ACTN4 SFPQ ATP1A1 AKAP8 HNRNPH1 MYEF2 HNRNPH2 HNRNPH3 PSMB6	9.54e-08	714	40	9	28302793
Pubmed	hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.	DNAJB1 SFPQ ATP1A1 AKAP8 HNRNPH1 HNRNPH2 HNRNPH3	1.28e-07	346	40	7	25324306
Pubmed	Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.	LIG3 SFPQ PFKP HNRNPH1 HNRNPH2 HNRNPH3	1.30e-07	206	40	6	22174317
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.66e-07	109	40	5	29511296
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	FLNC ACTN4 NUP188 ATP1A1 AKAP8 HNRNPH1 HNRNPH2 PSMB6	2.22e-07	564	40	8	21565611
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	FLNC IRS2 COL10A1 HNRNPH1 HNRNPH2 HNRNPH3	2.25e-07	226	40	6	25900982
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	LIG3 TAGLN2 IDH2 LDB1 AKAP8 HNRNPH2	2.25e-07	226	40	6	37839992
Pubmed	Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.	HNRNPH1 HNRNPH2 HNRNPH3	2.31e-07	11	40	3	21900255
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	LIG3 FLNC ACTN4 SFPQ RUNX1 PFKP HNRNPH1 MYEF2 HNRNPH2 HNRNPH3 PSMB6	2.42e-07	1353	40	11	29467282
Pubmed	A murine model of hnRNPH2-related neurodevelopmental disorder reveals a mechanism for genetic compensation by Hnrnph1.	HNRNPH1 HNRNPH2 HNRNPH3	3.08e-07	12	40	3	37463454
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	DNAJB1 ACTN4 IRS2 SFPQ TAGLN2 ATP1A1 PFKP HNRNPH1 HNRNPH2 HNRNPH3 PSMB6	3.79e-07	1415	40	11	28515276
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNC ACTN4 ITM2C SFPQ IDH2 ATP1A1 ATP1A3 PFKP HNRNPH1 MYEF2 PRNP	4.23e-07	1431	40	11	37142655
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	LIG3 ACTN4 SFPQ NUP188 HNRNPH1 HNRNPH2 HNRNPH3 PRNP	7.26e-07	660	40	8	32780723
Pubmed	RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.	DNAJB1 NUP188 AKAP8 HNRNPH1 HNRNPH2	7.61e-07	148	40	5	35676246
Pubmed	Tandem immunoprecipitation approach to identify HIV-1 Gag associated host factors.	HNRNPH1 HNRNPH2 HNRNPH3	7.81e-07	16	40	3	24690621
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	ACTN4 SFPQ TAGLN2 ATP1A1 LDB1 AKAP8 HNRNPH1 HNRNPH2 HNRNPH3	8.13e-07	922	40	9	27609421
Pubmed	TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.	LIG3 SFPQ NUP188 RUNX1 NKX2-1	8.68e-07	152	40	5	28192407
Pubmed	Downregulation of the FBXO43 gene inhibits tumor growth in human breast cancer by limiting its interaction with PCNA.	FLNC ACTN4 PFKP HNRNPH1	9.65e-07	65	40	4	34645483
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	LIG3 ACTN4 SFPQ ATP1A1 RUNX1 ATP1A3 PFKP HNRNPH1 HNRNPH3 PSMB6	1.08e-06	1247	40	10	27684187
Pubmed	TIF1gamma controls erythroid cell fate by regulating transcription elongation.	TCF4 LDB1 RUNX1	1.14e-06	18	40	3	20603019
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	DNAJB1 SFPQ NUP188 ATP1A1 AKAP8 PFKP HNRNPH1 HNRNPH2 HNRNPH3 PSMB6	1.16e-06	1257	40	10	37317656
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	FLNC ACTN4 SFPQ TAGLN2 NUP188 ATP1A1 HNRNPH3	1.21e-06	484	40	7	31995728
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	DNAJB1 RANBP10 FLNC ACTN4 IRS2 TAGLN2 NUP188 AKAP8 PFKP	1.28e-06	974	40	9	28675297
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	FLNC ACTN4 SFPQ ATP1A1 HNRNPH1 HNRNPH2 PSMB6	1.28e-06	488	40	7	31324722
Pubmed	Interaction between Oc-1 and Lmx1a promotes ventral midbrain dopamine neural stem cells differentiation into dopamine neurons.	ONECUT1 LMX1A	1.29e-06	2	40	2	25747864
Pubmed	Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.	ATP1A1 ATP1A3	1.29e-06	2	40	2	21498719
Pubmed	Transgelin-2: A potential oncogenic factor.	TAGLN2 TAGLN	1.29e-06	2	40	2	28639888
Pubmed	Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma.	TAGLN2 TAGLN	1.29e-06	2	40	2	19848416
Pubmed	Functional analysis of the nuclear LIM domain interactor NLI.	LDB1 LMX1A	1.29e-06	2	40	2	9315627
Pubmed	All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides.	ATP1A1 ATP1A3	1.29e-06	2	40	2	11546672
Pubmed	The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification.	LDB1 RUNX1	1.29e-06	2	40	2	29991720
Pubmed	The cellular prion protein interacts with and promotes the activity of Na,K-ATPases.	ATP1A1 PRNP	1.29e-06	2	40	2	34847154
Pubmed	Properties and expression of Na+/K+-ATPase α-subunit isoforms in the brain of the swamp eel, Monopterus albus, which has unusually high brain ammonia tolerance.	ATP1A1 ATP1A3	1.29e-06	2	40	2	24391932
Pubmed	Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.	TAGLN2 TAGLN	1.29e-06	2	40	2	24476357
Pubmed	Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia.	TCF4 RUNX1	1.29e-06	2	40	2	33054062
Pubmed	Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons.	ATP1A1 ATP1A3	1.29e-06	2	40	2	23761886
Pubmed	The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit.	ATP1A1 ATP1A3	1.29e-06	2	40	2	3030810
Pubmed	FGF signaling regulates development by processes beyond canonical pathways.	IRS2 COL10A1 NKX2-1	1.35e-06	19	40	3	33184218
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	FLNC SFPQ AKAP8 PFKP HNRNPH1 HNRNPH2 HNRNPH3	1.39e-06	494	40	7	26831064
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	DNAJB1 FLNC SFPQ TAGLN2 ATP1A1 AKAP8 HNRNPH1 HNRNPH2 HNRNPH3	1.45e-06	989	40	9	36424410
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	LIG3 TCF4 ACTN4 SFPQ EXTL3 ATP1A1 HNRNPH3	1.57e-06	503	40	7	36217030
Pubmed	Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis.	SFPQ AKAP8 HNRNPH1 MYEF2 HNRNPH2	1.60e-06	172	40	5	26336360
Pubmed	Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation.	TAGLN2 IDH2 ATP1A1 HNRNPH1 HNRNPH3 PSMB6	1.93e-06	327	40	6	34428256
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	DNAJB1 RANBP10 SFPQ NUP188 ATP1A1 AKAP8 HNRNPH1 HNRNPH2 HNRNPH3 PSMB6	1.99e-06	1335	40	10	29229926
Pubmed	Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex.	HNRNPH1 HNRNPH2 HNRNPH3	2.14e-06	22	40	3	18377426
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	FLNC ACTN4 SFPQ IDH2 HNRNPH1 PSMB6	2.19e-06	334	40	6	30425250
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	DNAJB1 FLNC ACTN4 TAGLN2 ATP1A1 TAGLN PFKP HNRNPH2 HNRNPH3 PSMB6	2.46e-06	1367	40	10	32687490
Pubmed	Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.	FLNC ACTN4 ATP1A1 ATP1A3 HNRNPH3 PRNP	2.46e-06	341	40	6	29791485
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	RANBP10 FLNC SFPQ AKAP8 HNRNPH1 HNRNPH2 HNRNPH3	2.86e-06	551	40	7	34728620
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	LIG3 FLNC SFPQ IDH2 AKAP8 HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.03e-06	1082	40	9	38697112
Pubmed	MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.	PSMB8 ACTN4 TAGLN2 ATP1A1 PFKP SLAMF1 PSMB6	3.37e-06	565	40	7	20458337
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DNAJB1 LIG3 ACTN4 SFPQ TAGLN2 NUP188 IDH2 ATP1A1 HNRNPH1 HNRNPH3	3.56e-06	1425	40	10	30948266
Pubmed	Human transcription factor protein interaction networks.	BCL9L LIG3 TCF4 ATP1A1 LDB1 AKAP8 PFKP NKX2-4 HNRNPH3 PSMB6	3.65e-06	1429	40	10	35140242
Pubmed	Three differentially expressed Na,K-ATPase alpha subunit isoforms: structural and functional implications.	ATP1A1 ATP1A3	3.87e-06	3	40	2	2822726
Pubmed	A novel complex, RUNX1-MYEF2, represses hematopoietic genes in erythroid cells.	RUNX1 MYEF2	3.87e-06	3	40	2	22801375
Pubmed	Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes.	ATP1A1 ATP1A3	3.87e-06	3	40	2	30819023
Pubmed	Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na+/K+-ATPase.	ATP1A1 ATP1A3	3.87e-06	3	40	2	27836549
Pubmed	Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase.	ATP1A1 ATP1A3	3.87e-06	3	40	2	26373354
Pubmed	Differential expression of Na+/K+-ATPase alpha-subunits in mouse hippocampal interneurones and pyramidal cells.	ATP1A1 ATP1A3	3.87e-06	3	40	2	17947306
Pubmed	Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders.	ATP1A1 ATP1A3	3.87e-06	3	40	2	19058785
Pubmed	Knockout of sodium pump α3 subunit gene (Atp1a3-/-) results in perinatal seizure and defective respiratory rhythm generation.	ATP1A1 ATP1A3	3.87e-06	3	40	2	28465228
Pubmed	Developmental cell-specific regulation of Na(+)-K(+)-ATPase alpha 1-, alpha 2-, and alpha 3-isoform gene expression.	ATP1A1 ATP1A3	3.87e-06	3	40	2	8203495
Pubmed	hnRNPs H, H' and F behave differently with respect to posttranslational cleavage and subcellular localization.	HNRNPH1 HNRNPH2	3.87e-06	3	40	2	10456323
Pubmed	Na,K-ATPase and the role of alpha isoforms in behavior.	ATP1A1 ATP1A3	3.87e-06	3	40	2	18044013
Pubmed	Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase.	ATP1A1 ATP1A3	3.87e-06	3	40	2	26988030
Pubmed	Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model.	ATP1A1 ATP1A3	3.87e-06	3	40	2	26911348
Pubmed	Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues.	HNRNPH1 HNRNPH2	3.87e-06	3	40	2	14980514
Pubmed	Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.	HNRNPH1 HNRNPH2	3.87e-06	3	40	2	21068389
Pubmed	Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.	ATP1A1 ATP1A3	3.87e-06	3	40	2	25994790
Pubmed	Heterogeneous nuclear ribonucleoproteins H, H', and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes.	HNRNPH1 HNRNPH2	3.87e-06	3	40	2	7499401
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	RANBP10 FLNC ACTN4 ITM2C SFPQ IDH2 ATP1A1 PFKP HNRNPH1 PRNP	4.18e-06	1451	40	10	30550785
Pubmed	Quantitative analysis of PPT1 interactome in human neuroblastoma cells.	DNAJB1 ATP1A1 HNRNPH1 HNRNPH2 HNRNPH3	4.24e-06	210	40	5	26217791
Pubmed	The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes.	FLNC ACTN4 SFPQ PFKP HNRNPH1	4.44e-06	212	40	5	23463506
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	FLNC ACTN4 SFPQ TAGLN2 PFKP HNRNPH1 HNRNPH2 PSMB6	4.50e-06	844	40	8	25963833
Pubmed	Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice.	ACTN4 IDH2 ATP1A1	4.53e-06	28	40	3	30947518
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	BCL9L ACTN4 ITM2C SFPQ IDH2 MYEF2 HNRNPH2 PRNP PSMB6	4.60e-06	1139	40	9	36417873
Pubmed	Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.	FLNC ATP1A1 AKAP8 PFKP HNRNPH1	4.75e-06	215	40	5	30462309
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	TCF4 LDB1 RUNX1	5.60e-06	30	40	3	26593974
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	FLNC SFPQ TAGLN2 IDH2 ATP1A1 PSMB6	5.89e-06	397	40	6	21319273
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	DNAJB1 FLNC SFPQ HNRNPH1 HNRNPH2 HNRNPH3	6.06e-06	399	40	6	35987950
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	DNAJB1 SFPQ ATP1A1 HNRNPH1 HNRNPH2 HNRNPH3	7.18e-06	411	40	6	35182466
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	FLNC ACTN4 ATP1A1 PFKP HNRNPH1 HNRNPH2	7.18e-06	411	40	6	36652389
Pubmed	Paralogous sm22alpha (Tagln) genes map to mouse chromosomes 1 and 9: further evidence for a paralogous relationship.	TAGLN2 TAGLN	7.73e-06	4	40	2	9693045
Interaction	USP48 interactions	ACTN4 SFPQ NUP188 ATP1A1 ATP1A3 PFKP HNRNPH1 MYEF2 HNRNPH2 PRNP PSMB6	3.52e-08	668	39	11	int:USP48
Interaction	AR interactions	BCL9L LIG3 TCF4 ACTN4 SFPQ NUP188 LDB1 RUNX1 HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.16e-07	992	39	12	int:AR
Interaction	VCAM1 interactions	FLNC ACTN4 SFPQ TAGLN2 NUP188 ATP1A3 HNRNPH1 HNRNPH3 PSMB6	2.35e-07	475	39	9	int:VCAM1
Interaction	MIR29B2 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.47e-07	71	39	5	int:MIR29B2
Interaction	MIR29B1 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.84e-07	73	39	5	int:MIR29B1
Interaction	MIR20A interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.04e-07	74	39	5	int:MIR20A
Interaction	MIR15A interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.25e-07	75	39	5	int:MIR15A
Interaction	MIR429 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.48e-07	76	39	5	int:MIR429
Interaction	MIR9-2 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.71e-07	77	39	5	int:MIR9-2
Interaction	MIR200A interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.71e-07	77	39	5	int:MIR200A
Interaction	MIR222 interactions	SFPQ RUNX1 HNRNPH1 HNRNPH2 HNRNPH3	4.22e-07	79	39	5	int:MIR222
Interaction	CIC interactions	LIG3 SFPQ ATP1A1 LDB1 RUNX1 PFKP NKX2-4 HNRNPH1 HNRNPH2 PRNP	4.27e-07	673	39	10	int:CIC
Interaction	IQCB1 interactions	FLNC ACTN4 NUP188 ATP1A1 AKAP8 HNRNPH1 HNRNPH2 PSMB6	4.48e-07	370	39	8	int:IQCB1
Interaction	PER2 interactions	FLNC ACTN4 SFPQ TAGLN2 HNRNPH2 HNRNPH3	4.60e-07	153	39	6	int:PER2
Interaction	MIR31 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	5.74e-07	84	39	5	int:MIR31
Interaction	MIR17 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	6.09e-07	85	39	5	int:MIR17
Interaction	MIR93 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	6.09e-07	85	39	5	int:MIR93
Interaction	MIR9-1 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	6.09e-07	85	39	5	int:MIR9-1
Interaction	MIR20B interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	6.46e-07	86	39	5	int:MIR20B
Interaction	OBSL1 interactions	PSMB8 FLNC ACTN4 SFPQ TAGLN2 NUP188 HNRNPH1 MYEF2 HNRNPH2 HNRNPH3 PSMB6	7.19e-07	902	39	11	int:OBSL1
Interaction	MIR141 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	7.25e-07	88	39	5	int:MIR141
Interaction	HIPK4 interactions	NUP188 ATP1A1 AKAP8 PFKP	7.55e-07	37	39	4	int:HIPK4
Interaction	MIR29C interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	7.67e-07	89	39	5	int:MIR29C
Interaction	MIR221 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	8.11e-07	90	39	5	int:MIR221
Interaction	GATA4 interactions	DNAJB1 LIG3 SFPQ ATP1A1 HNRNPH1 HNRNPH2 HNRNPH3 PRNP	9.89e-07	411	39	8	int:GATA4
Interaction	MIR19B2 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.01e-06	94	39	5	int:MIR19B2
Interaction	MIRLET7F1 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.01e-06	94	39	5	int:MIRLET7F1
Interaction	MIR21 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.18e-06	97	39	5	int:MIR21
Interaction	MIR363 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.18e-06	97	39	5	int:MIR363
Interaction	MIR128-2 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.30e-06	99	39	5	int:MIR128-2
Interaction	MIRLET7B interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.44e-06	101	39	5	int:MIRLET7B
Interaction	MIRLET7D interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.44e-06	101	39	5	int:MIRLET7D
Interaction	MIR25 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.44e-06	101	39	5	int:MIR25
Interaction	NAT8L interactions	FLNC HNRNPH1 PRNP	1.46e-06	12	39	3	int:NAT8L
Interaction	MIRLET7A3 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.51e-06	102	39	5	int:MIRLET7A3
Interaction	VCP interactions	PSMB8 DNAJB1 ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 NKX2-1 HNRNPH1 HNRNPH2 HNRNPH3 PRNP PSMB6	1.61e-06	1435	39	13	int:VCP
Interaction	MIR19B1 interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.66e-06	104	39	5	int:MIR19B1
Interaction	MIR34A interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.66e-06	104	39	5	int:MIR34A
Interaction	CEBPB interactions	PSMB8 DNAJB1 LIG3 ACTN4 SFPQ TAGLN2 ATP1A1 RUNX1 AKAP8 NKX2-1 HNRNPH1 HNRNPH2 HNRNPH3	1.72e-06	1443	39	13	int:CEBPB
Interaction	PSMA3 interactions	PSMB8 ACTN4 SFPQ PFKP HNRNPH2 HNRNPH3 PRNP PSMB6	1.73e-06	443	39	8	int:PSMA3
Interaction	MIRLET7E interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	1.83e-06	106	39	5	int:MIRLET7E
Interaction	STIP1 interactions	DNAJB1 LIG3 ACTN4 SFPQ TAGLN2 NUP188 ATP1A1 TAGLN HNRNPH1 HNRNPH3 PRNP	2.10e-06	1006	39	11	int:STIP1
Interaction	MIR34B interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.20e-06	110	39	5	int:MIR34B
Interaction	MIRLET7I interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.62e-06	114	39	5	int:MIRLET7I
Interaction	ATXN1 interactions	SFPQ TAGLN2 EXTL3 IDH2 ATP1A1 LDB1 ATP1A3 PFKP HNRNPH1 MYEF2 HNRNPH2	2.87e-06	1039	39	11	int:ATXN1
Interaction	DTX2 interactions	BCL9L SFPQ LDB1 RUNX1 AKAP8 PFKP HNRNPH1	2.90e-06	330	39	7	int:DTX2
Interaction	MIRLET7G interactions	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.98e-06	117	39	5	int:MIRLET7G
Interaction	CUL7 interactions	ACTN4 ITM2C SFPQ TAGLN2 ATP1A1 PFKP HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	3.35e-06	845	39	10	int:CUL7
Interaction	NFKBID interactions	PSMB8 TCF4 RUNX1 HNRNPH1 MYEF2	3.37e-06	120	39	5	int:NFKBID
Interaction	CCDC8 interactions	LIG3 ACTN4 SFPQ NUP188 ATP1A1 AKAP8 PFKP HNRNPH1 HNRNPH3	3.43e-06	656	39	9	int:CCDC8
Interaction	BAP1 interactions	DNAJB1 LIG3 FLNC ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 AKAP8 PFKP HNRNPH1 PSMB6	4.22e-06	1314	39	12	int:BAP1
Interaction	MBNL1 interactions	PSMB8 IDH2 PLA2G4D HNRNPH1 HNRNPH2 HNRNPH3	7.77e-06	249	39	6	int:MBNL1
Interaction	PRNP interactions	FLNC ACTN4 COL10A1 IDH2 ATP1A1 ATP1A3 PFKP HNRNPH1 MYEF2 HNRNPH3 PRNP	8.11e-06	1158	39	11	int:PRNP
Interaction	AGR2 interactions	FLNC ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 PFKP HNRNPH1 MYEF2 PSMB6	8.12e-06	934	39	10	int:AGR2
Interaction	ITGA4 interactions	ACTN4 SFPQ TAGLN2 NUP188 PFKP HNRNPH1 HNRNPH3 PSMB6	8.20e-06	547	39	8	int:ITGA4
Interaction	FABP7 interactions	TAGLN2 TAGLN PRNP	8.70e-06	21	39	3	int:FABP7
Interaction	FURIN interactions	LIG3 FLNC ACTN4 ITM2C ATP1A1 PFKP	8.90e-06	255	39	6	int:FURIN
Interaction	MIR138-1 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	8.92e-06	68	39	4	int:MIR138-1
Interaction	SOX2 interactions	BCL9L RANBP10 LIG3 ACTN4 TAGLN2 LDB1 RUNX1 AKAP8 PFKP HNRNPH1 MYEF2 HNRNPH2	9.48e-06	1422	39	12	int:SOX2
Interaction	MIR9-3 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.00e-05	70	39	4	int:MIR9-3
Interaction	ESRRB interactions	LIG3 ATP1A1 RUNX1 AKAP8 HNRNPH1 HNRNPH2	1.04e-05	262	39	6	int:ESRRB
Interaction	MIR140 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.06e-05	71	39	4	int:MIR140
Interaction	MIR122 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.06e-05	71	39	4	int:MIR122
Interaction	CLUH interactions	LIG3 TAGLN2 IDH2 HNRNPH2 PRNP PSMB6	1.06e-05	263	39	6	int:CLUH
Interaction	FBXO43 interactions	FLNC ACTN4 PFKP HNRNPH1	1.25e-05	74	39	4	int:FBXO43
Interaction	SULT4A1 interactions	RUNX1 HNRNPH1 PRNP	1.32e-05	24	39	3	int:SULT4A1
Interaction	MIR7-3 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.39e-05	76	39	4	int:MIR7-3
Interaction	MIR16-1 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.39e-05	76	39	4	int:MIR16-1
Interaction	MIR199A2 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.39e-05	76	39	4	int:MIR199A2
Interaction	CFTR interactions	PSMB8 DNAJB1 FLNC ACTN4 ITM2C SFPQ TAGLN2 IDH2 ATP1A1 HNRNPH1 HNRNPH2 PSMB6	1.42e-05	1480	39	12	int:CFTR
Interaction	NUP35 interactions	PSMB8 BCL9L SFPQ NUP188 AKAP8 NKX2-1 MYEF2	1.49e-05	424	39	7	int:NUP35
Interaction	MIR92A1 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.54e-05	78	39	4	int:MIR92A1
Interaction	MIR98 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.54e-05	78	39	4	int:MIR98
Interaction	CBFA2T3 interactions	RANBP10 TCF4 LDB1 RUNX1	1.54e-05	78	39	4	int:CBFA2T3
Interaction	MIR451A interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.54e-05	78	39	4	int:MIR451A
Interaction	MIR206 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.62e-05	79	39	4	int:MIR206
Interaction	MIR1-2 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.62e-05	79	39	4	int:MIR1-2
Interaction	MIR34C interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.62e-05	79	39	4	int:MIR34C
Interaction	UBQLN2 interactions	DNAJB1 COL10A1 TAGLN2 IDH2 ATP1A1 HNRNPH1 HNRNPH2 HNRNPH3 PSMB6	1.65e-05	797	39	9	int:UBQLN2
Interaction	HDAC5 interactions	ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 MYEF2 HNRNPH2	1.68e-05	432	39	7	int:HDAC5
Interaction	MIR143 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.70e-05	80	39	4	int:MIR143
Interaction	MIR145 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.79e-05	81	39	4	int:MIR145
Interaction	NR4A2 interactions	SFPQ RUNX1 PRNP	1.90e-05	27	39	3	int:NR4A2
Interaction	MIR106A interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	1.97e-05	83	39	4	int:MIR106A
Interaction	MIR7-2 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.07e-05	84	39	4	int:MIR7-2
Interaction	MIR199A1 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.07e-05	84	39	4	int:MIR199A1
Interaction	MIR200B interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.07e-05	84	39	4	int:MIR200B
Interaction	RBM39 interactions	ACTN4 SFPQ ATP1A1 RUNX1 AKAP8 HNRNPH1 MYEF2 HNRNPH2 HNRNPH3 PSMB6	2.11e-05	1042	39	10	int:RBM39
Interaction	MIR107 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.17e-05	85	39	4	int:MIR107
Interaction	MIR18B interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.17e-05	85	39	4	int:MIR18B
Interaction	MIR16-2 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.17e-05	85	39	4	int:MIR16-2
Interaction	TEKTIP1 interactions	HNRNPH1 PRNP	2.18e-05	4	39	2	int:TEKTIP1
Interaction	MECP2 interactions	LIG3 FLNC SFPQ IDH2 AKAP8 NKX2-1 HNRNPH1 MYEF2 HNRNPH2 HNRNPH3 PRNP	2.19e-05	1287	39	11	int:MECP2
Interaction	MIR29A interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.37e-05	87	39	4	int:MIR29A
Interaction	SF1 interactions	DNAJB1 SFPQ TAGLN RUNX1 HNRNPH1 HNRNPH2	2.41e-05	304	39	6	int:SF1
Interaction	NKX2-1 interactions	LIG3 SFPQ NUP188 RUNX1 NKX2-1	2.42e-05	180	39	5	int:NKX2-1
Interaction	MIR138-2 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.48e-05	88	39	4	int:MIR138-2
Interaction	FN1 interactions	DNAJB1 FLNC ACTN4 SFPQ TAGLN2 PFKP HNRNPH1 HNRNPH2 HNRNPH3	2.69e-05	848	39	9	int:FN1
Interaction	MIR92A2 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.71e-05	90	39	4	int:MIR92A2
Interaction	MIR1-1 interactions	SFPQ HNRNPH1 HNRNPH2 HNRNPH3	2.71e-05	90	39	4	int:MIR1-1
Cytoband	Ensembl 112 genes in cytogenetic band chr1q23	TAGLN2 SLAMF1 LMX1A	1.02e-03	226	40	3	chr1q23
GeneFamily	RNA binding motif containing	SFPQ HNRNPH1 MYEF2 HNRNPH2 HNRNPH3	2.04e-05	213	29	5	725
GeneFamily	ATPase Na+/K+ transporting subunits	ATP1A1 ATP1A3	5.19e-05	7	29	2	1208
GeneFamily	Proteasome	PSMB8 PSMB6	2.15e-03	43	29	2	690
GeneFamily	NKL subclass homeoboxes and pseudogenes	NKX2-4 NKX2-1	5.15e-03	67	29	2	519
Coexpression	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	PSMB8 DNAJB1 ACTN4 ATP1A1	5.51e-06	76	40	4	M13396
Coexpression	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	SFPQ EXTL3 ATP1A1 TAGLN RUNX1	5.59e-06	168	40	5	M1124
Coexpression	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	PSMB8 DNAJB1 ACTN4 ATP1A1	6.11e-06	78	40	4	MM593
Coexpression	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	SFPQ EXTL3 ATP1A1 TAGLN RUNX1	8.25e-06	182	40	5	MM993
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING	PSMB8 DNAJB1 BCL9L TCF4 TAGLN2 HNRNPH3 PRNP PSMB6	1.10e-05	720	40	8	MM3700
Coexpression	GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP	RANBP10 TCF4 TAGLN2 GIMAP5 PSMB6	1.21e-05	197	40	5	M3480
Coexpression	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN	DNAJB1 RANBP10 ACTN4 TAGLN2 PLA2G4D	1.30e-05	200	40	5	M8572
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING	DNAJB1 ITM2C SFPQ TAGLN2 IDH2 ATP1A1	1.47e-05	352	40	6	MM3788
Coexpression	FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL	PSMB8 TCF4 ACTN4 SFPQ TAGLN2 ATP1A1	1.80e-05	365	40	6	M41711
Coexpression	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	FLNC ITM2C TAGLN2	2.27e-05	36	40	3	M11749
Coexpression	TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING	PSMB8 TCF4 ITM2C GIMAP5	2.47e-05	111	40	4	MM3831
Coexpression	BYSTRYKH_SCP2_QTL	LIG3 PSMB6	3.39e-05	6	40	2	M17138
Coexpression	JIANG_MELANOMA_TRM8_CD4	DNAJB1 TAGLN2 ATP1A1 CDC42SE2 SLAMF1 PRNP	4.28e-05	426	40	6	M48972
Coexpression	BYSTRYKH_SCP2_QTL	LIG3 PSMB6	4.75e-05	7	40	2	MM1140
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	FLNC ITM2C SFPQ PFKP PRNP PSMB6	6.95e-05	465	40	6	M9192
Coexpression	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	TCF4 HOXB7 ITM2C	8.18e-05	55	40	3	M16649
Coexpression	TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_B_CELL_AGEING	PSMB8 ITM2C TAGLN2 ATP1A1 PRNP	1.07e-04	311	40	5	MM3674
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_B_CELL_AGEING	PSMB8 TCF4 ITM2C CDC42SE2 GIMAP5	1.13e-04	315	40	5	MM3784
Coexpression	TAGHAVI_NEOPLASTIC_TRANSFORMATION	FLNC ACTN4	1.24e-04	11	40	2	M9267
Coexpression	GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP	BCL9L IDH2 AKAP8 HNRNPH3	1.42e-04	174	40	4	M8885
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	BCL9L ATP1A1 RUNX1 PRNP	1.52e-04	177	40	4	M9118
Coexpression	AMIT_EGF_RESPONSE_120_HELA	IRS2 TAGLN HNRNPH1	1.54e-04	68	40	3	M12710
Coexpression	AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4	ACTN4 IRS2 ATP1A1 PFKP	1.76e-04	184	40	4	M39135
Coexpression	TRAVAGLINI_LUNG_BASAL_CELL	TCF4 TAGLN2 HNRNPH1 PRNP	1.91e-04	188	40	4	M41651
Coexpression	TIEN_INTESTINE_PROBIOTICS_24HR_UP	TCF4 SFPQ TAGLN2 NUP188 TAGLN HNRNPH3	1.94e-04	561	40	6	M1463
Coexpression	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP	ITM2C IRS2 RUNX1 SLAMF1	2.03e-04	191	40	4	M8742
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	BCL9L ATP1A1 RUNX1 PRNP	2.07e-04	192	40	4	MM752
Coexpression	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	TCF4 IRS2 GBA2 PRNP	2.38e-04	199	40	4	M8119
Coexpression	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN	PSMB8 ITM2C SLAMF1 PRNP	2.38e-04	199	40	4	M4549
Coexpression	GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN	DNAJB1 HNRNPH1 HNRNPH2 HNRNPH3	2.38e-04	199	40	4	M8313
Coexpression	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	SFPQ EXTL3 RUNX1 ATP1A3	2.38e-04	199	40	4	MM991
Coexpression	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	SFPQ EXTL3 RUNX1 ATP1A3	2.38e-04	199	40	4	M2155
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN	TAGLN2 ATP1A1 SLAMF1 PRNP	2.38e-04	199	40	4	M4407
Coexpression	GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN	ACTN4 TAGLN2 PFKP SLAMF1	2.38e-04	199	40	4	M3107
Coexpression	GSE22886_TCELL_VS_BCELL_NAIVE_UP	DNAJB1 ATP1A1 RUNX1 GIMAP5	2.38e-04	199	40	4	M4425
Coexpression	GSE11057_CD4_EFF_MEM_VS_PBMC_UP	DNAJB1 ATP1A1 RUNX1 SLAMF1	2.38e-04	199	40	4	M3113
Coexpression	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP	DNAJB1 ATP1A1 RUNX1 GIMAP5	2.38e-04	199	40	4	M3084
Coexpression	GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN	DNAJB1 TCF4 CDC42SE2 HNRNPH3	2.42e-04	200	40	4	M6301
Coexpression	GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN	LDB1 GBA2 HNRNPH1 MYEF2	2.42e-04	200	40	4	M7996
Coexpression	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	SFPQ CDC42SE2 ATP1A3 PRNP	2.42e-04	200	40	4	M6620
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN	LIG3 TAGLN2 NKX2-1 SLAMF1	2.42e-04	200	40	4	M3747
Coexpression	GSE2826_XID_VS_BTK_KO_BCELL_DN	ITM2C PFKP MYEF2 PRNP	2.42e-04	200	40	4	M4901
Coexpression	GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN	ITM2C ATP1A1 AKAP8 CDC42SE2	2.42e-04	200	40	4	M8506
Coexpression	GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN	ITM2C AKAP8 CDC42SE2 HNRNPH2	2.42e-04	200	40	4	M8524
Coexpression	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	DNAJB1 TAGLN2 IDH2 PLA2G4D	2.42e-04	200	40	4	M7446
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	BCL9L TCF4 TAGLN2 RUNX1 HNRNPH1 HNRNPH3 PRNP	2.56e-04	843	40	7	M2356
Coexpression	FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL	SFPQ ATP1A1 HNRNPH1 HNRNPH3 PRNP	2.70e-04	380	40	5	M41703
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING	DNAJB1 ACTN4 ITM2C SFPQ HNRNPH1	3.19e-04	394	40	5	MM3724
Coexpression	FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL	DNAJB1 SFPQ TAGLN HNRNPH1	4.19e-04	231	40	4	M41719
Coexpression	TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING	PSMB8 TCF4 ITM2C TAGLN2	4.19e-04	231	40	4	MM3741
Coexpression	FAN_OVARY_CL18_B_LYMPHOCYTE	TCF4 ACTN4 ITM2C TAGLN2 CDC42SE2	4.37e-04	422	40	5	M41720
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE	PFKP SLAMF1	4.68e-04	21	40	2	M40944
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	LIG3 HNRNPH1	4.68e-04	21	40	2	M12459
Coexpression	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	TCF4 SFPQ PFKP HNRNPH2 HNRNPH3 PSMB6	4.95e-04	669	40	6	M18635
Coexpression	SAGIV_CD24_TARGETS_UP	SFPQ LDB1	5.15e-04	22	40	2	M4144
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING	PSMB8 DNAJB1 BCL9L ITM2C TAGLN2 PRNP	5.61e-04	685	40	6	MM3782
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	PSMB8 ACTN4 SFPQ TAGLN2 IDH2 ATP1A1 RUNX1 PFKP	5.89e-04	1276	40	8	M39173
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	PSMB8 ITM2C IRS2 ATP1A1 PRNP	6.27e-04	457	40	5	M14507
Coexpression	OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP	LIG3 IDH2	6.66e-04	25	40	2	M40987
Coexpression	LAIHO_COLORECTAL_CANCER_SERRATED_UP	TCF4 TAGLN2 PRNP	7.22e-04	115	40	3	M16586
Coexpression	TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL	IRS2 SFPQ ATP1A1 RUNX1 SLAMF1 PRNP	7.50e-04	724	40	6	M41700
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN4 SFPQ ATP1A1 CDC42SE2 HNRNPH1 HNRNPH2	2.15e-08	196	40	6	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgG_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PSMB8 DNAJB1 ITM2C IDH2 TAGLN RUNX1	2.21e-08	197	40	6	6b0941883e40bd82c65659b97a4752e8e32ac190
ToppCell	control-Myeloid-Monocyte-derived_DC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ACTN4 IDH2 CDC42SE2 HNRNPH2 HNRNPH3	4.47e-08	108	40	5	e74e73d89d78c8d59dfdd2bd30db54b366a49d23
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJB1 BCL9L IRS2 SFPQ TAGLN2	6.69e-07	186	40	5	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC ACTN4 TAGLN RUNX1 HNRNPH2	8.89e-07	197	40	5	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	NS-control-d_0-4-Myeloid-Monocyte-derived_DC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IDH2 CDC42SE2 HNRNPH2 HNRNPH3	5.11e-06	127	40	4	1f9039d2a9e418c41716c3608d4d03574b71904a
ToppCell	control-Myeloid-Monocyte-derived_DC\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	IDH2 CDC42SE2 HNRNPH2 HNRNPH3	5.28e-06	128	40	4	4a1f7b76b64df06531db79e427eda084374ce7b5
ToppCell	Control-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	FLNC EXTL3 LDB1 GIMAP5	7.11e-06	138	40	4	b7920c9a28d28220e7e4b30cd91ba13d0548eb76
ToppCell	10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8\|Lung / Manually curated celltypes from each tissue	DNAJB1 ITM2C SLAMF1 GIMAP5	1.65e-05	171	40	4	c8ccb7795ce8321739e3bc07db2ffc183d04e660
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB1 CDC42SE2 SLAMF1 HNRNPH1	1.81e-05	175	40	4	f456d8d958b71f7a942b718605712593d9de1bfd
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 TCF4 ITM2C GIMAP5	1.85e-05	176	40	4	11067b649fe21ac2bb328829ecadc2f64c2c10aa
ToppCell	droplet-Spleen-nan-21m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 TCF4 ITM2C GIMAP5	1.85e-05	176	40	4	130238f0707541c511f479619c4f7a3593ef0ebf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC ACTN4 TAGLN PSMB6	1.94e-05	178	40	4	c661246269ce26c4fc62e12f86c5f90a2dcfdce0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC ACTN4 TAGLN PSMB6	1.94e-05	178	40	4	e5e5f5b4a27e120a1076b1cb250fa25d0c336956
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITM2C RUNX1 PFKP GIMAP5	2.02e-05	180	40	4	41e8155cc7b3dac9d496e4077845ca6af1591a5c
ToppCell	ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TCF4 ITM2C RUNX1 HNRNPH1	2.40e-05	188	40	4	2156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	FLNC TAGLN2 TAGLN PRNP	2.50e-05	190	40	4	ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB1 IRS2 ATP1A1 RUNX1	2.55e-05	191	40	4	9bb6a6b88f351217455765ba07a6acf11fda98f4
ToppCell	hematopoetic_progenitors-CD34+_CLP\|World / Lineage and Cell class	TCF4 ITM2C IDH2 ATP1A3	2.55e-05	191	40	4	32f2537c97c9984629d61c6f34a337f555146ad4
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	PSMB8 ACTN4 ITM2C IDH2	2.55e-05	191	40	4	2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITM2C ATP1A1 HNRNPH1 PRNP	2.60e-05	192	40	4	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SFPQ TAGLN2 ATP1A1 PRNP	2.60e-05	192	40	4	3e2a0f332e7f9833ba88f3c809cee78b65090401
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DNAJB1 IDH2 CDC42SE2 GIMAP5	2.60e-05	192	40	4	ed1fb700d3e8f00495727d61e164fc0b70274fd0
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DNAJB1 IDH2 CDC42SE2 GIMAP5	2.60e-05	192	40	4	6779b0294bb058e748e22b795b6a381c4add37e9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB1 IRS2 CDC42SE2 HNRNPH1	2.66e-05	193	40	4	4e78ddc96d8e403a21c4a303b1f26512d2ac91e8
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC ACTN4 TAGLN RUNX1	2.77e-05	195	40	4	5ed995717bd3d35cd66442e6e84fe18fe0f7cf96
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRS2 RUNX1 HNRNPH1 HNRNPH2	2.82e-05	196	40	4	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DNAJB1 ITM2C IDH2 TAGLN	2.82e-05	196	40	4	a8217c8e27027c0444ce072fe194404345c34022
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRS2 RUNX1 HNRNPH1 HNRNPH2	2.82e-05	196	40	4	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SFPQ SLAMF1 HNRNPH1 PRNP	2.82e-05	196	40	4	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLNC ITM2C IRS2 MYEF2	2.82e-05	196	40	4	45d1c0a962c4221c17393ee5566961d1deebf442
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN4 ATP1A1 TAGLN RUNX1	2.88e-05	197	40	4	f4dad4423384a2a25e064c849ffccf2811573be0
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	BCL9L IRS2 SFPQ PRNP	2.88e-05	197	40	4	fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCF4 ACTN4 ATP1A1 HNRNPH1	2.88e-05	197	40	4	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DNAJB1 TCF4 ATP1A3 NKX2-1	2.88e-05	197	40	4	b4554353c56e220bae31ee3c8aa222674dd0b18c
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 ACTN4 ATP1A1 HNRNPH1	2.88e-05	197	40	4	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	normal_Lung-T/NK_cells-CD4+_Th\|T/NK_cells / Location, Cell class and cell subclass	DNAJB1 ITM2C TAGLN2 SLAMF1	2.88e-05	197	40	4	80b3902ceea242148a1f1707c633f66afedf5183
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ITM2C TAGLN PFKP PSMB6	2.88e-05	197	40	4	4e0c3ea4f4a04a41532806edf3bccf7845c86fa5
ToppCell	normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	PSMB8 ACTN4 ITM2C IDH2	2.88e-05	197	40	4	2bf540fa228687a71f595a807e4a2af20588a82c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_small-bowel / Manually curated celltypes from each tissue	IRS2 TAGLN2 SLAMF1 PRNP	2.94e-05	198	40	4	f4fc0cac858fc6dcd779d7959ccec51f78ea8cc2
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN4 ATP1A1 HNRNPH1 HNRNPH2	2.94e-05	198	40	4	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	IRS2 TAGLN2 CDC42SE2 SLAMF1	2.94e-05	198	40	4	6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DNAJB1 CDC42SE2 SLAMF1 GIMAP5	2.94e-05	198	40	4	58f208b76cb0adcecdf632d92f92833a06f9bf71
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	ACTN4 ITM2C TAGLN2 TAGLN	2.94e-05	198	40	4	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN4 ATP1A1 HNRNPH1 HNRNPH2	2.94e-05	198	40	4	22559b161e67b49fe8028bfaf861e069063599f5
ToppCell	(2)_NK/T-(23)_CD4+_T_cell-(231)_CD4+/CD45RO+_Memory_T_cell\|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization)	ACTN4 TAGLN2 PFKP PRNP	2.94e-05	198	40	4	cd1548fc27779ada721ca00c72ebd3b6c9b15a19
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN4 ATP1A1 HNRNPH1 HNRNPH2	2.94e-05	198	40	4	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	facs-Tongue-nan-3m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN4 ATP1A1 HNRNPH1 HNRNPH2	3.00e-05	199	40	4	8d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCell	lymphoid-NK_cell-NK_cell\|NK_cell / Lineage, cell class and subclass	SFPQ CDC42SE2 HNRNPH1 HNRNPH3	3.00e-05	199	40	4	945fbf5845403a8b22d04963f50ad69c414b6153
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FLNC ACTN4 TAGLN PFKP	3.05e-05	200	40	4	2bc7f462a551292de2501028164573935232f899
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_Tem\|Leuk-UTI / Disease, condition lineage and cell class	HOXB7 CDC42SE2 SLAMF1 GIMAP5	3.05e-05	200	40	4	65ea3ba16c75f8e9a5aee3ba0c7ab11a961fff7c
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FLNC ACTN4 TAGLN PFKP	3.05e-05	200	40	4	8b80a65b69b36ed405214564b939452c90aa40d6
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	COL10A1 TAGLN RUNX1	3.88e-05	73	40	3	116259a036373bccaeb77fe3c675741a5ca81c52
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COL10A1 NKX2-4 ONECUT1	4.37e-05	76	40	3	f653a09d6707d9b34db4ef486212aeba5610f47b
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COL10A1 NKX2-4 ONECUT1	4.37e-05	76	40	3	47deea63d975366a42834c22cc163c4c7142d51d
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	COL10A1 NKX2-4 ONECUT1	4.37e-05	76	40	3	079e1af894e670f63d718e16599f20d920643160
ToppCell	droplet-Skin-nan-18m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF18 TAGLN LMX1A	1.92e-04	125	40	3	5a309ce803d2b8efd791eb21808121bf5fc3ea8e
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SFPQ HNRNPH1 HNRNPH3	2.46e-04	136	40	3	0185486c39700dd2f72d79be6d283494dd8379c9
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SFPQ HNRNPH1 HNRNPH3	2.46e-04	136	40	3	3e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCell	ASK454-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	TAGLN2 ATP1A1 NKX2-1	3.21e-04	149	40	3	078792d5272f1881757dc47daa96e87449cf5d34
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITM2C IDH2 ATP1A1	3.47e-04	153	40	3	98670bbce4a770af244f033cdd2d54db57200ca8
ToppCell	367C-Lymphocytic-ILC-ILC-3\|367C / Donor, Lineage, Cell class and subclass (all cells)	ITM2C ATP1A3 SLAMF1	3.47e-04	153	40	3	9d64aadbb4bb28469af1d728457b431e21577429
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|368C / Donor, Lineage, Cell class and subclass (all cells)	CDC42SE2 ATP1A3 MYEF2	3.82e-04	158	40	3	390b9c455ed15a6804613eecfd2776949dfba146
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUNX1 ATP1A3 PFKP	3.82e-04	158	40	3	90ca742739a208d457db087655ba3d1c18a9da57
ToppCell	10x5'-Liver-Lymphocytic_T_CD8-Trm_gut_CD8\|Liver / Manually curated celltypes from each tissue	ITM2C SLAMF1 GIMAP5	3.82e-04	158	40	3	1197604ea63eb7cae58985d39a2c9de1724e2866
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUNX1 ATP1A3 PFKP	3.96e-04	160	40	3	8dae9b0cf90a09acb196223f45a14680102630b2
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DNAJB1 IRS2 SLAMF1	3.96e-04	160	40	3	21f7c0337fbd99e4a20650920d8302d7318bd25e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC TAGLN2 HNRNPH2	4.03e-04	161	40	3	6582dc295b6f66de95a00b70fa55a8e69a3e4c8f
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PSMB8 TAGLN2 GIMAP5	4.03e-04	161	40	3	a60ef3f390f56bb05b687b17986fe6382f69f260
ToppCell	BL-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RUNX1 SLAMF1 PRNP	4.11e-04	162	40	3	25ec9df914445b4daae4fd28fd0e60b64797c46d
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell-Endo\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PSMB8 TAGLN2 GIMAP5	4.11e-04	162	40	3	0bdb1e5ba33e162bec1acb28256c1405a7658ee5
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HOXB7 TAGLN HNRNPH2	4.11e-04	162	40	3	b24298910eb39ea5103ae24439b3901205ed55b6
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PSMB8 TAGLN2 GIMAP5	4.11e-04	162	40	3	5799a602ef8d83925907e8e34532428be7330228
ToppCell	356C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	TCF4 ITM2C SLAMF1	4.18e-04	163	40	3	ae9c5eb19657ea94b7f2357cbc8679acd697b8fe
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	TCF4 ITM2C LDB1	4.18e-04	163	40	3	2913ccdd4613472cd82077d4993e1d9f8b223398
ToppCell	Healthy_Control-Lymphoid-Plasma-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	TCF4 ITM2C LDB1	4.18e-04	163	40	3	b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCell	356C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TCF4 ITM2C MYEF2	4.25e-04	164	40	3	fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a
ToppCell	367C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TCF4 ITM2C ATP1A3	4.25e-04	164	40	3	95b800c78871354c859abaa832d778786ef7bcc0
ToppCell	IIF-Lymphocyte-T_NK-CD8_TCM\|IIF / Disease, Lineage and Cell Type	DNAJB1 ITM2C CDC42SE2	4.41e-04	166	40	3	f3f289eb9fa52abf0226ec711302022a07a6f345
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HOXB7 ATP1A3 PFKP	4.49e-04	167	40	3	3b717d33aaf1ef0869cc4bca8432ba8008875cc5
ToppCell	normal_Lung-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	DNAJB1 ITM2C IDH2	4.56e-04	168	40	3	76b49463895cdef27c90f831c6246bcb92b9761b
ToppCell	Posterior_cortex-Endothelial-MURAL\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACTN4 TAGLN2 TAGLN	4.64e-04	169	40	3	0ae65daf092396b71f790b65c7a2feed90397417
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ACTN4 TAGLN2 TAGLN	4.64e-04	169	40	3	8cd70ce27b1cecb83f8a376230e7ef41b079b124
ToppCell	normal_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	ACTN4 ITM2C TAGLN	4.72e-04	170	40	3	d69c0ea4cb6b204f19d0a5d2164afb42184779ac
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 SLAMF1 GIMAP5	4.72e-04	170	40	3	6086d658a52a1961a1e293cbc3703ae8d309cd11
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAJB1 IRS2 SLAMF1	4.81e-04	171	40	3	7b0783d25055e5ea5b2fc44ebcb16bfd0adbcf81
ToppCell	facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDH2 ATP1A1 PFKP	4.89e-04	172	40	3	bc1b889ac5e07b8324ae5837eca911f9c865e959
ToppCell	droplet-Spleen-nan-21m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 TCF4 ITM2C	4.89e-04	172	40	3	3dc02709c2a6be2155576e5c34e1b0b3ae19b061
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 SLAMF1 GIMAP5	4.89e-04	172	40	3	f320813177f246926bfd5862b4e0f9bd828cebab
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 SLAMF1 GIMAP5	4.89e-04	172	40	3	b3c12a4bb08ce931de6fe800b605f3e43adea0b5
ToppCell	facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDH2 ATP1A1 PFKP	4.89e-04	172	40	3	ba70b6110b70afb1870e8dcaf58c507b8c7d918e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC EXTL3 TAGLN	4.97e-04	173	40	3	3001dd39244ef0a5a475d569a78f4ae427a55db6
ToppCell	Ionocyte-iono-2\|World / Class top	CDC42SE2 PFKP MYEF2	4.97e-04	173	40	3	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC EXTL3 TAGLN	4.97e-04	173	40	3	c88883fb2a33e21d4201aa393674aa3f2ad780c9
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC HOXB7 LMX1A	5.06e-04	174	40	3	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC ITM2C TAGLN	5.14e-04	175	40	3	c6c0196875f3b5293083cda6718300806a801941
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DNAJB1 ITM2C SLAMF1	5.14e-04	175	40	3	6374ab186d7ccf7f6dfb858267edba8962789e15
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNC ITM2C TAGLN	5.14e-04	175	40	3	82c4d1edaa0d3b82d3ef4676d6f6516104a2656a
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 ATP1A1 PLA2G4D	5.23e-04	176	40	3	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSMB8 TCF4 CDC42SE2	5.23e-04	176	40	3	35610e7ac9902687e222641202409bab279c3998
Drug	alpha-methyl-D-mannoside	COL10A1 IDH2 ATP1A1 ATP1A3 GBA2	1.80e-06	116	40	5	CID000002108
Drug	2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	IDH2 HNRNPH1 HNRNPH2 HNRNPH3 PSMB6	9.50e-06	163	40	5	ctd:D015647
Drug	Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	DNAJB1 FLNC IRS2 NUP188 RUNX1	1.94e-05	189	40	5	3373_UP
Drug	Hydrocortisone base [50-23-7]; Up 200; 11uM; PC3; HT_HG-U133A	LIG3 COL10A1 LDB1 RUNX1 ATP1A3	2.10e-05	192	40	5	6684_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A	TCF4 EXTL3 LDB1 RUNX1 HNRNPH1	2.15e-05	193	40	5	6699_DN
Drug	Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A	LIG3 IRS2 EXTL3 RUNX1 HNRNPH1	2.20e-05	194	40	5	2091_DN
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ITM2C IRS2 NUP188 RUNX1 ONECUT1	2.37e-05	197	40	5	4403_UP
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; HL60; HG-U133A	RANBP10 LIG3 RUNX1 HNRNPH1 HNRNPH3	2.49e-05	199	40	5	1390_UP
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A	LIG3 IRS2 TAGLN RUNX1 HNRNPH1	2.49e-05	199	40	5	6496_DN
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; HL60; HT_HG-U133A	LIG3 LDB1 HNRNPH1 HNRNPH3 PRNP	2.49e-05	199	40	5	1290_UP
Drug	Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A	NUP188 TAGLN RUNX1 ATP1A3 NKX2-1	2.55e-05	200	40	5	5445_UP
Drug	22,23-dihydrobufalin	ATP1A1 ATP1A3	3.00e-05	5	40	2	CID000195392
Drug	3-acetylstrophanthin	ATP1A1 ATP1A3	3.00e-05	5	40	2	CID003082282
Drug	thevetin A	ATP1A1 ATP1A3	3.00e-05	5	40	2	CID000441873
Drug	ETH157	ATP1A1 ATP1A3	4.49e-05	6	40	2	CID000563154
Drug	CID6432277	ATP1A1 ATP1A3 HNRNPH3	5.11e-05	41	40	3	CID006432277
Drug	dihydrodigitoxigenin	ATP1A1 ATP1A3	6.28e-05	7	40	2	CID000107549
Drug	bromovanin	ACTN4 SFPQ TAGLN2 HNRNPH2	7.22e-05	127	40	4	ctd:C515564
Drug	AC1MBZB6	ATP1A1 ATP1A3	1.08e-04	9	40	2	CID002733620
Drug	glutamin	PSMB8 DNAJB1 SFPQ MYEF2 PRNP PSMB6	1.43e-04	461	40	6	CID000000738
Drug	2-methylaconitate	IDH2 PRNP	1.64e-04	11	40	2	CID000000345
Drug	ouabagenin	ATP1A1 ATP1A3	1.64e-04	11	40	2	CID000010497
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	DNAJB1 IRS2 SFPQ RUNX1	2.03e-04	166	40	4	5826_UP
Drug	A-32686	ATP1A1 ATP1A3	2.32e-04	13	40	2	CID000004951
Drug	Parthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	DNAJB1 IRS2 TAGLN RUNX1	2.38e-04	173	40	4	5105_UP
Drug	Bilirubin	DNAJB1 TCF4 IDH2 ATP1A1	2.54e-04	176	40	4	ctd:D001663
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	HOXB7 AKAP8 HNRNPH1 PRNP	2.59e-04	177	40	4	3177_DN
Drug	alpha-methylisocitrate	IDH2 PRNP	2.70e-04	14	40	2	CID000000513
Drug	Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A	IRS2 COL10A1 RUNX1 HNRNPH1	2.71e-04	179	40	4	4721_UP
Drug	trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A	LIG3 RUNX1 AKAP8 PRNP	2.71e-04	179	40	4	331_DN
Drug	Ketone Bodies	TCF4 IDH2 ATP1A1 LDB1 PFKP HNRNPH1	2.79e-04	522	40	6	ctd:D007657
Drug	L-3,4-dehydroproline	COL10A1 EXTL3 RUNX1	2.87e-04	73	40	3	CID000094284
Drug	aluminum	IDH2 ATP1A1 HNRNPH3 PRNP	3.01e-04	184	40	4	CID000104727
Drug	6-o-phosphonohexose	DNAJB1 IDH2 PFKP PRNP	3.07e-04	185	40	4	CID000099058
Drug	lomustine; Up 200; 100uM; MCF7; HT_HG-U133A	DNAJB1 LIG3 LDB1 PRNP	3.07e-04	185	40	4	7045_UP
Drug	NSC-84513	ATP1A1 ATP1A3	3.11e-04	15	40	2	CID000256927
Drug	Haloperidol	ATP1A1 TAGLN ATP1A3 PFKP GIMAP5	3.17e-04	342	40	5	ctd:D006220
Drug	Azacytidine-5 [320-67-2]; Down 200; 16.4uM; PC3; HT_HG-U133A	DNAJB1 TCF4 SFPQ RUNX1	3.39e-04	190	40	4	4010_DN
Drug	Ebselen [60940-34-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A	DNAJB1 IRS2 NUP188 RUNX1	3.39e-04	190	40	4	3458_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	SFPQ IDH2 TAGLN RUNX1	3.46e-04	191	40	4	2634_DN
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	LIG3 TCF4 EXTL3 LDB1	3.53e-04	192	40	4	7065_DN
Drug	GSK-3beta Inhibitor VIII; Down 200; 10uM; MCF7; HT_HG-U133A	DNAJB1 IRS2 SFPQ HNRNPH1	3.53e-04	192	40	4	7092_DN
Drug	UVA1	IRS2 SLAMF1	3.56e-04	16	40	2	CID000015797
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	TCF4 NUP188 LDB1 RUNX1	3.60e-04	193	40	4	4536_UP
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; PC3; HT_HG-U133A	LIG3 IDH2 RUNX1 HNRNPH1	3.60e-04	193	40	4	6733_UP
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	LIG3 HNRNPH1 HNRNPH3 PRNP	3.60e-04	193	40	4	6835_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A	RANBP10 IDH2 LDB1 RUNX1	3.67e-04	194	40	4	2430_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; PC3; HT_HG-U133A	TCF4 TAGLN LDB1 HNRNPH1	3.67e-04	194	40	4	6651_DN
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	IRS2 COL10A1 RUNX1 HNRNPH1	3.67e-04	194	40	4	5701_UP
Drug	17-AAG; Up 200; 0.1uM; MCF7; HG-U133A	DNAJB1 RANBP10 IRS2 TAGLN	3.75e-04	195	40	4	221_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	RANBP10 LIG3 TCF4 RUNX1	3.75e-04	195	40	4	2064_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	RANBP10 LIG3 IRS2 RUNX1	3.75e-04	195	40	4	4533_DN
Drug	nocodazole; Up 200; 1uM; MCF7; HG-U133A	RANBP10 LIG3 SFPQ EXTL3	3.75e-04	195	40	4	621_UP
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A	TCF4 LDB1 RUNX1 HNRNPH1	3.75e-04	195	40	4	2468_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A	LIG3 TCF4 IDH2 RUNX1	3.75e-04	195	40	4	4664_DN
Drug	Ethacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	DNAJB1 LIG3 TCF4 COL10A1	3.75e-04	195	40	4	3181_UP
Drug	1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	HOXB7 SFPQ IDH2 HNRNPH2	3.82e-04	196	40	4	2_DN
Drug	Roxarsone [121-19-7]; Up 200; 15.2uM; HL60; HT_HG-U133A	COL10A1 NUP188 EXTL3 RUNX1	3.82e-04	196	40	4	2950_UP
Drug	6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; HL60; HT_HG-U133A	LIG3 COL10A1 RUNX1 ATP1A3	3.82e-04	196	40	4	2511_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	TCF4 ITM2C RUNX1 ATP1A3	3.82e-04	196	40	4	6402_DN
Drug	Ebselen [60940-34-3]; Down 200; 14.6uM; PC3; HT_HG-U133A	LIG3 TCF4 EXTL3 LDB1	3.89e-04	197	40	4	5778_DN
Drug	Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; HL60; HG-U133A	RANBP10 FLNC COL10A1 NUP188	3.89e-04	197	40	4	1779_UP
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A	TCF4 TAGLN RUNX1 ATP1A3	3.89e-04	197	40	4	6732_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	LIG3 ITM2C IRS2 RUNX1	3.89e-04	197	40	4	3899_DN
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	LIG3 EXTL3 RUNX1 HNRNPH1	3.89e-04	197	40	4	3540_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; ssMCF7; HG-U133A	RANBP10 IRS2 RUNX1 HNRNPH3	3.89e-04	197	40	4	497_DN
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A	RANBP10 EXTL3 LDB1 RUNX1	3.89e-04	197	40	4	7386_DN
Drug	Anabasine [494-52-0]; Up 200; 24.6uM; HL60; HT_HG-U133A	LIG3 COL10A1 RUNX1 ATP1A3	3.89e-04	197	40	4	2512_UP
Drug	Lansoprazole [103577-45-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	LIG3 EXTL3 RUNX1 HNRNPH1	3.89e-04	197	40	4	6009_UP
Drug	resorcinol	DNAJB1 TAGLN HNRNPH2 HNRNPH3	3.89e-04	197	40	4	ctd:C031389
Drug	Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A	RANBP10 ITM2C EXTL3 RUNX1	3.89e-04	197	40	4	2620_UP
Drug	Azapropazone [13539-59-8]; Up 200; 13.4uM; PC3; HT_HG-U133A	FLNC SFPQ LDB1 HNRNPH1	3.89e-04	197	40	4	7277_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A	LIG3 EXTL3 LDB1 ONECUT1	3.89e-04	197	40	4	4754_DN
Drug	magnesium	LIG3 ACTN4 IDH2 ATP1A1 ATP1A3 PFKP GBA2 PRNP PSMB6	3.95e-04	1325	40	9	CID000000888
Drug	Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; PC3; HT_HG-U133A	LIG3 HOXB7 RUNX1 HNRNPH1	3.97e-04	198	40	4	4228_UP
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ITM2C COL10A1 RUNX1 HNRNPH1	3.97e-04	198	40	4	6800_UP
Drug	Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; HL60; HT_HG-U133A	FLNC EXTL3 RUNX1 ATP1A3	3.97e-04	198	40	4	1838_UP
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A	TCF4 RUNX1 ATP1A3 HNRNPH1	3.97e-04	198	40	4	1522_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; HL60; HT_HG-U133A	LIG3 EXTL3 TAGLN RUNX1	3.97e-04	198	40	4	2188_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	IDH2 TAGLN LDB1 RUNX1	3.97e-04	198	40	4	5731_DN
Drug	Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A	ITM2C IRS2 LDB1 RUNX1	3.97e-04	198	40	4	6799_UP
Drug	Ronidazole [7681-76-7]; Up 200; 20uM; MCF7; HT_HG-U133A	FLNC EXTL3 ATP1A3 ONECUT1	3.97e-04	198	40	4	3557_UP
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	LIG3 IRS2 EXTL3 AKAP8	3.97e-04	198	40	4	3175_DN
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A	DNAJB1 TCF4 COL10A1 EXTL3	3.97e-04	198	40	4	6178_UP
Drug	topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA	LIG3 ITM2C EXTL3 IDH2	3.97e-04	198	40	4	915_UP
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; HL60; HT_HG-U133A	RANBP10 TCF4 LDB1 HNRNPH1	3.97e-04	198	40	4	3024_DN
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; HL60; HT_HG-U133A	TCF4 EXTL3 TAGLN RUNX1	3.97e-04	198	40	4	2155_DN
Drug	Trimethadione [127-48-0]; Down 200; 28uM; MCF7; HT_HG-U133A	IRS2 NUP188 EXTL3 LDB1	3.97e-04	198	40	4	2846_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A	LIG3 NUP188 EXTL3 RUNX1	3.97e-04	198	40	4	347_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A	TCF4 RUNX1 ATP1A3 ONECUT1	3.97e-04	198	40	4	3548_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; HL60; HG-U133A	DNAJB1 LIG3 TCF4 EXTL3	3.97e-04	198	40	4	1775_UP
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; HL60; HT_HG-U133A	LIG3 TCF4 TAGLN HNRNPH1	3.97e-04	198	40	4	2154_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	LIG3 HOXB7 COL10A1 NKX2-1	3.97e-04	198	40	4	3059_UP
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A	FLNC ITM2C ATP1A3 ONECUT1	3.97e-04	198	40	4	4413_UP
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A	FLNC ITM2C IRS2 RUNX1	3.97e-04	198	40	4	5243_UP
Drug	valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A	TCF4 COL10A1 NUP188 RUNX1	3.97e-04	198	40	4	6378_DN
Drug	HDMA	ATP1A1 ATP1A3	4.03e-04	17	40	2	CID000131092
Drug	linamarin	IDH2 GBA2	4.03e-04	17	40	2	CID000011128
Drug	Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	IRS2 COL10A1 EXTL3 RUNX1	4.05e-04	199	40	4	1509_UP
Drug	Calciferol [50-14-6]; Down 200; 10uM; HL60; HT_HG-U133A	LIG3 TAGLN LDB1 RUNX1	4.05e-04	199	40	4	2442_DN
Disease	lung adenocarcinoma (is_marker_for)	HOXB7 COL10A1 IDH2 RUNX1	4.88e-06	85	39	4	DOID:3910 (is_marker_for)
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A1 ATP1A3	3.56e-05	7	39	2	DOID:0060178 (implicated_via_orthology)
Disease	nervous system disease (implicated_via_orthology)	ATP1A1 ATP1A3	1.11e-04	12	39	2	DOID:863 (implicated_via_orthology)
Disease	monocyte count	TCF4 ITM2C IRS2 ATP1A1 RUNX1 ATP1A3 ONECUT1 LMX1A	2.80e-04	1320	39	8	EFO_0005091
Disease	Ventricular Dysfunction, Left	IDH2 ATP1A3	7.23e-04	30	39	2	C0242698
Disease	cups of coffee per day measurement	ATP1A1 ATP1A3	1.29e-03	40	39	2	EFO_0006782

Protein segments in the cluster

Peptide	Gene	Start	Entry
YGVMGMQGAGGYDST	AKAP8	256	O43823
GAGGGGSMGDYMAQE	ACTN4	21	O43707
MGMGGFTNVNFGRSR	DNAJB1	136	P25685
NMSGMGGLGSLGDVS	NKX2-1	136	P43699
GYMGIGLSAQGVNMN	RANBP10	116	Q6VN20
GGMMVRQSFAIGGSG	PSMB6	151	P28072
QYRGMGLSMGSMICG	PSMB8	161	P28062
AMGSYCNGGLGNMGE	NKX2-4	106	Q9H2Z4
MSGGSTMSSGGGNTN	LDB1	301	Q86U70
SMAYGQIGMIQALGG	ATP1A1	851	P05023
SGMNQPGYAGMLGNS	TCF4	231	P15884
IQNQMQSKGGYGGGM	CDC42SE2	56	Q9NRR3
GASGGAYGSQMMGGM	HNRNPH2	386	P55795
AYGSQMMGGMGLSNQ	HNRNPH2	391	P55795
MMGGMGLSNQSSYGG	HNRNPH2	396	P55795
NGGGSAGMEGIMNPY	LMX1A	276	Q8TE12
ETMGGYCGYLANMGG	PFKP	581	Q01813
MMNNSGYSDAGLGLG	FLNC	1	Q14315
RSMGMASLLDGGSGG	ONECUT1	51	Q9UBC0
DNQGGYGSVGRMGMG	HNRNPH3	291	P31942
YGSVGRMGMGNNYSG	HNRNPH3	296	P31942
RMGMGNNYSGGYGTP	HNRNPH3	301	P31942
GASGGAYGSQMMGGM	HNRNPH1	386	P31943
AYGSQMMGGMGLSNQ	HNRNPH1	391	P31943
MMGGMGLSNQSSYGG	HNRNPH1	396	P31943
GAFYGQGSKGGMMSI	LIG3	696	P49916
RGGSVGGVCYLSMGM	ITM2C	51	Q9NQX7
MGGFQRGKYGTMAEG	GIMAP5	1	Q96F15
FAASMQGLYPGGGGM	HOXB7	51	P09629
RDGGGGGEFYGYMTM	IRS2	531	Q9Y4H2
NFPAGGVGMGMYNTD	IDH2	211	P48735
QAFAGGAMGAVNGMQ	GBA2	791	Q9HCG7
MTGYTMLRNGGAGNG	EXTL3	1	O43909
GGQGPYQAMSQDMGN	BCL9L	851	Q86UU0
SMAYGQIGMIQALGG	ATP1A3	841	P13637
GNQALYGGQMMTSTG	KLF18	481	A0A0U1RQI7
MATGGGARAMTSLYG	PLA2G4D	326	Q86XP0
GIGIGMSAMGSATRY	RUNX1	336	Q01196
NRGASQAGMTGYGMP	TAGLN2	181	P37802
LEAMNSMGGFGGVGR	MYEF2	386	Q9P2K5
SMGGFGGVGRMGELY	MYEF2	391	Q9P2K5
GGVGRMGELYRGAMT	MYEF2	396	Q9P2K5
SLAFGASYGTGGRMM	SLAMF1	16	Q13291
GLQMGSNRGASQAGM	TAGLN	176	Q01995
VPGMNGQKGEMGYGA	COL10A1	181	Q03692
GAMNMGDPYGSGGQK	SFPQ	616	P23246
QMISAEGMNAGGYGN	NUP188	651	Q5SRE5
EGMNAGGYGNLLMNS	NUP188	656	Q5SRE5
VVGGLGGYMLGSAMS	PRNP	121	P04156